#rarediseases

Live, measured metrics for the hashtag #rarediseases from the open social web. Every number carries a named source and the time it was fetched. Nothing is estimated.

hashtag.org network · sponsored

Own #rarediseases

This #name is available to claim. It becomes your portal on the open agent web: this very page, a keyword you rank for by an open public stake, and a verifiable identity for AI agents. Nobody else sells a page like this for every #name.

$5.00/ year · 12-character #name
Claim #rarediseases$5.00/yr
Annual, renews each year
Buy on hashtag.space (web3)
one-timepay once, yours for life
card via hashtag.org · tokens via hashtag.space
0
Uses / 7 days
Mastodon
0
Accounts / 7 days
Mastodon
40
Recent posts
Mastodon
~0/hr
Recent pace
Mastodon · last 40
0
Avg reactions / post
Mastodon · last 40

Day-by-day usage

measured · fosstodon.org (Mastodon public tags API) · fetched 2026-07-27 02:55 UTC
0
07-21
0
07-22
0
07-23
0
07-24
0
07-25
0
07-26
0
07-27

0 uses by 0 unique accounts across the window. Real per-day counts, not estimates. Newest bar is today so far.

Related hashtags

measured · fosstodon.org (Mastodon public search API) · fetched 2026-07-27 02:55 UTC

Live pulse

measured · fosstodon.org (Mastodon tag timeline) · fetched 2026-07-27 02:55 UTC

Everything below is measured over the latest 40 public posts (spanning ~5225 hours).

Posting hours (UTC) — busiest: 06:00

00:0012:0023:00

Languages: English (36) · German (3)

Avg boosts / post: 0.4

Top of the latest posts

  • 💡 A genuine surprise: The active ingredient in #Viagra, sildenafil, helps treat a rare genetic disorder! This unexpected finding has now been uncovered by researchers at #CharitéBerlin. The drug showed positive effects on the course of the

    Charité Berlin@[email protected]112026-03-11 16:15 UTCView post →
  • Soligenix advances rare disease innovation using platform science to expand its therapeutic pipeline and address unmet medical needs affecting millions. #RareDiseases #Biotech

    Newsramp@[email protected]002026-05-16 07:03 UTCView post →
  • Soligenix reports strong Phase 3 HyBryte data for cutaneous T-cell lymphoma, with response rates exceeding expectations. Interim analysis could accelerate commercialization path. #Biotech #RareDiseases

    Newsramp@[email protected]002026-05-16 06:53 UTCView post →

Every number above is measured from a named public API at the shown fetch time. Nothing is estimated or extrapolated. Platforms that lock their data behind paid APIs are not shown. Agents: the same numbers, as JSON, at /api/hashtags/rarediseases